Cancer Pain Market 2027 By Drug Type, Disease Indication | The Insight Partners

Cancer Pain Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Drug Type (Opioids, Non-Opioids, Nerve blockers); Disease Indication (Lung Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Blood Cancer, Others)

Report Code: TIPRE00007742 | No. of Pages: 151 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Cancer pain is a cancer disease, and because of the chronic and progressive nature of the disease, cancer pain is a common cause of chronic pain. Cancer pain results from tissue damage either due to the disease itself or due to treatment. Cancer pain is caused due to tumor pressing on bones, nerves, or other organs in the body. Sometimes the pain is due to your cancer treatment. For example, some chemotherapy drugs can cause numbness and tingle in your hands and feet.

MARKET DYNAMICS

The cancer pain market is anticipated to grow in the market by the increase in the incidence of cancer worldwide, surge in healthcare expenditure, and advancements in technology. However, adverse effects related to the usage of drugs for cancer pain management restrain cancer pain market growth. Moreover, the surge in several pipeline drugs creates new opportunities in the industry that drive the market growth.

MARKET SCOPE

The "Cancer Pain Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of in cancer pain market with detailed market segmentation by drug type, disease indication and geography. The cancer pain market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in cancer pain market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The cancer pain market is segmented on the basis of drug type and by disease indication. Based on drug type the market is segmented as opioids, non-opioids and nerve blockers. On the basis of disease indication the market is categorized as lung cancer, colorectal cancer, breast cancer, prostate cancer, blood cancer and others.



Get more information on this report :

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in cancer pain market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The cancer pain market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting cancer pain market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the cancer pain market in these regions.




Get more information on this report :

MARKET PLAYERS


The report covers key developments in the in cancer pain market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in cancer pain market are anticipated to have lucrative growth opportunities in the future with the rising demand for in cancer pain market in the global market. Below mentioned is the list of few companies engaged in the cancer pain market.

The report also includes the profiles of key in cancer pain market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Aoxing Pharmaceutical Company, Inc.
  •  BioDelivery Sciences International, Inc.
  •  Daiichi Sankyo Co., Ltd.
  •  Grunenthal Pharma GmbH & Co. KG,
  •  Hisamitsu Pharmaceutical Co., Inc.
  •  Insys Therapeutics, Inc.
  •  Mundipharma International Limited
  •  Orexo AB
  •  Pfizer Inc.
  •  Teva Pharmaceutical Industries Limited

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Cancer Pain Market - By Drug Type
1.3.2 Cancer Pain Market - By Disease Indication
1.3.3 Cancer Pain Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CANCER PAIN MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CANCER PAIN MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. CANCER PAIN MARKET - GLOBAL MARKET ANALYSIS
6.1. CANCER PAIN - GLOBAL MARKET OVERVIEW
6.2. CANCER PAIN - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. CANCER PAIN MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. OPIOIDS
7.3.1. Overview
7.3.2. Opioids Market Forecast and Analysis
7.4. NON-OPIOIDS
7.4.1. Overview
7.4.2. Non-Opioids Market Forecast and Analysis
7.5. NERVE BLOCKERS
7.5.1. Overview
7.5.2. Nerve blockers Market Forecast and Analysis
8. CANCER PAIN MARKET - REVENUE AND FORECASTS TO 2027 - DISEASE INDICATION
8.1. OVERVIEW
8.2. DISEASE INDICATION MARKET FORECASTS AND ANALYSIS
8.3. LUNG CANCER
8.3.1. Overview
8.3.2. Lung Cancer Market Forecast and Analysis
8.4. COLORECTAL CANCER
8.4.1. Overview
8.4.2. Colorectal Cancer Market Forecast and Analysis
8.5. BREAST CANCER
8.5.1. Overview
8.5.2. Breast Cancer Market Forecast and Analysis
8.6. PROSTATE CANCER
8.6.1. Overview
8.6.2. Prostate Cancer Market Forecast and Analysis
8.7. BLOOD CANCER
8.7.1. Overview
8.7.2. Blood Cancer Market Forecast and Analysis
8.8. OTHERS
8.8.1. Overview
8.8.2. Others Market Forecast and Analysis
9. CANCER PAIN MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Cancer Pain Market Overview
9.1.2 North America Cancer Pain Market Forecasts and Analysis
9.1.3 North America Cancer Pain Market Forecasts and Analysis - By Drug Type
9.1.4 North America Cancer Pain Market Forecasts and Analysis - By Disease Indication
9.1.5 North America Cancer Pain Market Forecasts and Analysis - By Countries
9.1.5.1 United States Cancer Pain Market
9.1.5.1.1 United States Cancer Pain Market by Drug Type
9.1.5.1.2 United States Cancer Pain Market by Disease Indication
9.1.5.2 Canada Cancer Pain Market
9.1.5.2.1 Canada Cancer Pain Market by Drug Type
9.1.5.2.2 Canada Cancer Pain Market by Disease Indication
9.1.5.3 Mexico Cancer Pain Market
9.1.5.3.1 Mexico Cancer Pain Market by Drug Type
9.1.5.3.2 Mexico Cancer Pain Market by Disease Indication
9.2. EUROPE
9.2.1 Europe Cancer Pain Market Overview
9.2.2 Europe Cancer Pain Market Forecasts and Analysis
9.2.3 Europe Cancer Pain Market Forecasts and Analysis - By Drug Type
9.2.4 Europe Cancer Pain Market Forecasts and Analysis - By Disease Indication
9.2.5 Europe Cancer Pain Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Cancer Pain Market
9.2.5.1.1 Germany Cancer Pain Market by Drug Type
9.2.5.1.2 Germany Cancer Pain Market by Disease Indication
9.2.5.2 France Cancer Pain Market
9.2.5.2.1 France Cancer Pain Market by Drug Type
9.2.5.2.2 France Cancer Pain Market by Disease Indication
9.2.5.3 Italy Cancer Pain Market
9.2.5.3.1 Italy Cancer Pain Market by Drug Type
9.2.5.3.2 Italy Cancer Pain Market by Disease Indication
9.2.5.4 Spain Cancer Pain Market
9.2.5.4.1 Spain Cancer Pain Market by Drug Type
9.2.5.4.2 Spain Cancer Pain Market by Disease Indication
9.2.5.5 United Kingdom Cancer Pain Market
9.2.5.5.1 United Kingdom Cancer Pain Market by Drug Type
9.2.5.5.2 United Kingdom Cancer Pain Market by Disease Indication
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Cancer Pain Market Overview
9.3.2 Asia-Pacific Cancer Pain Market Forecasts and Analysis
9.3.3 Asia-Pacific Cancer Pain Market Forecasts and Analysis - By Drug Type
9.3.4 Asia-Pacific Cancer Pain Market Forecasts and Analysis - By Disease Indication
9.3.5 Asia-Pacific Cancer Pain Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Cancer Pain Market
9.3.5.1.1 Australia Cancer Pain Market by Drug Type
9.3.5.1.2 Australia Cancer Pain Market by Disease Indication
9.3.5.2 China Cancer Pain Market
9.3.5.2.1 China Cancer Pain Market by Drug Type
9.3.5.2.2 China Cancer Pain Market by Disease Indication
9.3.5.3 India Cancer Pain Market
9.3.5.3.1 India Cancer Pain Market by Drug Type
9.3.5.3.2 India Cancer Pain Market by Disease Indication
9.3.5.4 Japan Cancer Pain Market
9.3.5.4.1 Japan Cancer Pain Market by Drug Type
9.3.5.4.2 Japan Cancer Pain Market by Disease Indication
9.3.5.5 South Korea Cancer Pain Market
9.3.5.5.1 South Korea Cancer Pain Market by Drug Type
9.3.5.5.2 South Korea Cancer Pain Market by Disease Indication
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Cancer Pain Market Overview
9.4.2 Middle East and Africa Cancer Pain Market Forecasts and Analysis
9.4.3 Middle East and Africa Cancer Pain Market Forecasts and Analysis - By Drug Type
9.4.4 Middle East and Africa Cancer Pain Market Forecasts and Analysis - By Disease Indication
9.4.5 Middle East and Africa Cancer Pain Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Cancer Pain Market
9.4.5.1.1 South Africa Cancer Pain Market by Drug Type
9.4.5.1.2 South Africa Cancer Pain Market by Disease Indication
9.4.5.2 Saudi Arabia Cancer Pain Market
9.4.5.2.1 Saudi Arabia Cancer Pain Market by Drug Type
9.4.5.2.2 Saudi Arabia Cancer Pain Market by Disease Indication
9.4.5.3 U.A.E Cancer Pain Market
9.4.5.3.1 U.A.E Cancer Pain Market by Drug Type
9.4.5.3.2 U.A.E Cancer Pain Market by Disease Indication
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Cancer Pain Market Overview
9.5.2 South and Central America Cancer Pain Market Forecasts and Analysis
9.5.3 South and Central America Cancer Pain Market Forecasts and Analysis - By Drug Type
9.5.4 South and Central America Cancer Pain Market Forecasts and Analysis - By Disease Indication
9.5.5 South and Central America Cancer Pain Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Cancer Pain Market
9.5.5.1.1 Brazil Cancer Pain Market by Drug Type
9.5.5.1.2 Brazil Cancer Pain Market by Disease Indication
9.5.5.2 Argentina Cancer Pain Market
9.5.5.2.1 Argentina Cancer Pain Market by Drug Type
9.5.5.2.2 Argentina Cancer Pain Market by Disease Indication
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. CANCER PAIN MARKET, KEY COMPANY PROFILES
11.1. AOXING PHARMACEUTICAL COMPANY, INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BIODELIVERY SCIENCES INTERNATIONAL, INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. DAIICHI SANKYO CO., LTD.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. GRUNENTHAL PHARMA GMBH AND CO. KG,
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. HISAMITSU PHARMACEUTICAL CO., INC.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. INSYS THERAPEUTICS, INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. MUNDIPHARMA INTERNATIONAL LIMITED
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. OREXO AB
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. PFIZER INC.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. TEVA PHARMACEUTICAL INDUSTRIES LIMITED
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Aoxing Pharmaceutical Company, Inc.
2. BioDelivery Sciences International, Inc.
3. Daiichi Sankyo Co., Ltd.
4. Grunenthal Pharma GmbH & Co. KG,
5. Hisamitsu Pharmaceutical Co., Inc.
6. Insys Therapeutics, Inc.
7. Mundipharma International Limited
8. Orexo AB
9. Pfizer Inc.
10. Teva Pharmaceutical Industries Limited
TIPRE00007742
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking